The focus on rare diseases by the pharmaceutical industry is a dangerous trend that is stifling innovation and is bad news for cardiovascular disease, the President of the European Society has warned. Speaking at the CSANZ ASM here in Adelaide Professor Babara Casadei who is also a British Heart Foundation Professor and Honorary Consultant Cardiologist ...
Industry focus on orphan drugs a dangerous trend warns ESC President
By Nicola Garrett
10 Aug 2019